Overview
New Zealand is among the highest scoring in the Policy Context category due to a strong national asthma strategy and severe asthma guidelines, and the country’s reporting to severe asthma registries. New Zealand’s score could be improved by addressing its limited alignment of national care guidelines with international best practices and comparatively modest tobacco control laws. New Zealand’s score in terms of Access and Care Coverage is average. New Zealand has high levels of access to treatment and some diagnostics (inflammatory phenotyping), though limited access to biologics, FeNO-based diagnostics and specialised care.
How does New Zealand perform in each category?
Provides further insights into how New Zealand scores across each Index category
New Zealand takeaways
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in New Zealand
New Zealand has a strong asthma strategy and existence of severe asthma guidelines
New Zealand is limited in its alignment of national care guidelines with international best practices
New Zealand has limited access to biologics, FeNO-based diagnostics and specialised care
Compare New Zealand to other countries
Select different countries to see how they scored across each of the 5 categories and overall